As childhood obesity and youth-onset type 2 diabetes mellitus (T2DM) continue to rise worldwide, a new systematic review highlights glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as promising options that extend beyond lifestyle modification and metformin
Nevertheless, metformin remains the typical first-line choice because of its well-established safety profile, efficacy, low cost, and wide accessibility (Wexler 2021b)
Developing potential therapies that can be administered less frequently could benefit societies as well as individual patients, and it is a clear focus area for Novo Nordisk, commented Brian Vandahl, Senior Vice President of Global Research Technologies at Novo Nordisk
A.GhafooriH.FarahmandZ.MohammadKhaniE.VakhshitehF.et al (2018)
Customers waited an average of 5 hours at our pop-up store.
Subcutaneous injection angle When giving the shot, insert the full length of the needle at a 45- to 90-degree angle into your skin fold